Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

143.50p
   
  • Change Today:
      1.50p
  • 52 Week High: 148.00p
  • 52 Week Low: 107.50p
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 400
  • Market Cap: 152.44m
  • RiskGrade: 131
Select chart: 1 week
 

Current

6 month

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 146.43 13.10 9.29p 15.3 5.1 +3% 2.67p 1.9%
31-Dec-20 171.04 14.10 9.59p 14.8 4.6 +3% 4.15p 2.9%
31-Dec-21 174.88 15.00 10.07p 14.1 2.8 +5% 4.39p 3.1%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (m)
31-Dec-2020 171 171 n/a n/a n/a n/a
31-Dec-2021 175 175 n/a n/a n/a n/a
 
Earnings
31-Dec-2020 9.59p 9.59p n/a n/a n/a n/a
31-Dec-2021 10.07p 10.07p n/a n/a n/a n/a
 
Dividend
31-Dec-2020 4.15p 4.15p n/a n/a n/a n/a
31-Dec-2021 4.39p 4.39p n/a n/a n/a n/a
 
Recommendations
Strong Buy 1 1 0 0 0 0
Buy 0 0 0 0 0 0
Neutral 1 1 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 2 2 0 0 0 0
 
Average Rec 7.50 7.50 n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Cello Health Market Data

Currency UK Pounds
Share Price 143.50p
Change Today 1.50p
% Change 1.06 %
52 Week High 148.00p
52 Week Low 107.50p
Volume 400
Shares Issued 106.23m
Market Cap 152.44m
RiskGrade 131

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.34% below the market average74.34% below the market average74.34% below the market average74.34% below the market average74.34% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
60.18% above the market average60.18% above the market average60.18% above the market average60.18% above the market average60.18% above the market average
46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average46.34% above the sector average
Income
22.42% below the market average22.42% below the market average22.42% below the market average22.42% below the market average22.42% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
30.31% below the market average30.31% below the market average30.31% below the market average30.31% below the market average30.31% below the market average
60% below the sector average60% below the sector average60% below the sector average60% below the sector average60% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-19 25-Apr-19
Paid 01-Nov-19 24-May-19
Amount 1.15p 2.75p

Trades for 17-Feb-2020

Time Volume / Share Price
10:14 400 @ 143.85p

Cello Health Key Personnel

CEO Mark Scott

Top of Page